Bio-Connect
Western blot analysis of extracts from COS7 cells treated with Anisomycin using Phospho-ALK (Tyr1507) antibody.The lane on the right is treated with the antigen-specific peptide.
Western blot analysis of extracts from COS7 cells treated with Anisomycin using Phospho-ALK (Tyr1507) antibody.The lane on the right is treated with the antigen-specific peptide.
Western blot analysis of extracts from COS7 cells treated with Anisomycin using Phospho-ALK (Tyr1507) antibody.The lane on the right is treated with the antigen-specific peptide.

Phospho-ALK (Tyr1507) Antibody

Research Use Only
CSB-PA209313
Cusabio
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetALK
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cusabio
  • Product Name
    Phospho-ALK (Tyr1507) Antibody
  • Delivery Days Customer
    20
  • Applications
    Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID238
  • Target name
    ALK
  • Target description
    ALK receptor tyrosine kinase
  • Target synonyms
    ALK tyrosine kinase receptor; anaplastic lymphoma receptor tyrosine kinase; CD246; CD246 antigen; mutant anaplastic lymphoma kinase; NBLST3
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9UM73
  • Protein Name
    ALK tyrosine kinase receptor
  • Scientific Description
    Neuronal orphan receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system. Transduces signals from ligands at the cell surface, through specific activation of the mitogen-activated protein kinase (MAPK) pathway. Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif. Following activation by ligand, ALK induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Acts as a receptor for ligands pleiotrophin (PTN), a secreted growth factor, and midkine (MDK), a PTN-related factor, thus participating in PTN and MDK signal transduction. PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation. MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction. Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase. Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK. Degoutin J, Vigny M, Gouzi JY (2007) FEBS Lett 581, 727-34.
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C
  • UNSPSC
    12352203